Introduction
============

Diabetes mellitus is a chronic disease characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both ([@b1-mmr-17-03-3697]). According to insulin-dependent and non-insulin-dependent, adult diabetes is classified: Type 1 and type 2 diabetes. A genetic defect on insulin was found in type 1 diabetes, whereas insulin resistance is the key metabolic abnormality in type 2 diabetes ([@b2-mmr-17-03-3697]). In addition, maternal diabetes in pregnancy is defined as glucose intolerance or first recognition during pregnancy, who is easy to happen type 2 diabetes postpartum ([@b3-mmr-17-03-3697]). Besides, maternal diabetes in pregnancy is related to an increased risk of congenital heart defects (CHD), macrosomia, miscarriage, and other birth defects in offspring ([@b4-mmr-17-03-3697],[@b5-mmr-17-03-3697]). CHD was defined as deficits of the structure and function arising from cardiac embryogenesis stage ([@b6-mmr-17-03-3697]). It has been reported that CHD is the major consequences in diabetic embryopathy ([@b7-mmr-17-03-3697]).

An infant born to a diabetic mother has been shown to exhibit axial mesodermal dysplasia spectrum with atrioventricular septal defects ([@b8-mmr-17-03-3697]). Many studies have reported that maternal diabetes altered expression of genes in developmental embryo ([@b4-mmr-17-03-3697],[@b9-mmr-17-03-3697],[@b10-mmr-17-03-3697]). *Bmp4*, belongs to the TGF-β superfamily, is a myocardial signaling molecule which activated epithelial-mesenchymal transition (EMT) during cardiogenesis ([@b11-mmr-17-03-3697]). The expression of *Bmp4* has been reported to be downregulated by the *Msx1* that expressed in atrioventricular canal endocardial cells during EMT ([@b12-mmr-17-03-3697],[@b13-mmr-17-03-3697]). *Pax3* is also essential for heart formation and outflow tract development in the mouse embryo ([@b14-mmr-17-03-3697]). Study showed that the downregulation of *Bmp4*, *Msx1* and *Pax3* could contribute to the pathogenesis of maternal diabetes-induced CHD ([@b15-mmr-17-03-3697]). In addition, it has been reported that hyperglycemia altered the expression of *eNOC* and *VEGF* that are involved in the regulation of vasculogenesis ([@b16-mmr-17-03-3697]). Furthermore, a recent study on microarray analysis showed that several genes were altered in embryonic heart tissues from diabetic mother and were closely associated with CHD, such as *Smyd1*, *Tsc1* and *Gja1* ([@b4-mmr-17-03-3697]). However, the exact pathogenesis of CHD in offspring of diabetic mother is still unknown.

In this study, we explored the gene expression profiles of embryonic heart tissue samples at embryonic day 13.5 (E13.5) and embryonic day 15.5 (E15.5) from diabetic mice, and their respective controls. The differentially expressed genes (DEGs) were screened in E13.5 and E15.5 groups. Gene Ontology (GO) functions, Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome pathway enrichment analyses were then performed to identify the DEGs. We also constructed the protein-protein interaction (PPI) networks for the DEGs and analyzed several important shared genes that were associated with CHD. Our study aimed to identify the critical genes that might be involved in CHD in offspring of diabetic mother and to provide evidence to further clarify the relationship between CHD and diabetes.

Materials and methods
=====================

### Affymetrix microarray data

The gene expression profile of GSE32078 was obtained from the study of Vijaya *et al* ([@b4-mmr-17-03-3697]), which was deposited in Gene Expression Omnibus (GEO) database (<http://www.ncbi.nlm.nih.gov/geo/>) of National Center of Biotechnology Information (NCBI). A total of 12 samples were available, including three embryonic heart tissue samples at E13.5 and three embryonic heart tissue samples at E15.5 from streptozotocin-induced diabetic Swiss albino mice (8--10 weeks), as well as their respective controls from normal mice. The day when a copulation plug was observed was counted as E0.5. Raw data were collected with the Affymetrix Mouse Genome 430 2.0 Array (Affymetrix, CA, USA). All raw data files were pretreated by RMA method in Affy package ([@b17-mmr-17-03-3697]).

### Screening of DEGs

The Linear Models for Microarray Data (LIMMA) package ([@b18-mmr-17-03-3697]) was used to identify DEGs. All genes were tested with *F*-test and the DEGs with the threshold P-value \<0.08 were screened.

### GO and KEGG pathway enrichment analysis

ClusterProfiler, a new ontology-based tool, offers three methods (group GO, enrich GO, enrich KEGG) for genes classification and enrichment analyses ([@b19-mmr-17-03-3697],[@b20-mmr-17-03-3697]). ClusterProfiler package was used to identify the main biological processes and metabolic pathways in DEGs. Default parameters (organism, mouse; ont, BP; P-value cut-off, 0.05; P-adjust method, none; readable, T) were used as the cut-off criteria for GO function enrichment analysis. And the default parameters (organism, mouse; P-value cut-off, 1; q-value cut-off, 1; readable, 1) were used as the cut-off criteria for KEGG pathway enrichment analysis.

### Reactome pathway enrichment analysis

ReactomePA package was used to identify the main biological processes and metabolic pathways in DEGs ([@b21-mmr-17-03-3697],[@b22-mmr-17-03-3697]). Default parameters (organism, mouse; P-value cut-off, 1; q-value cut-off, 1; minGSSize, 1; readable, 1) were used as the cut-off criteria for Reactome pathway enrichment analysis.

### PPI network construction

The Search Tool for the Retrieval of Interacting Genes (STRING) database was used to obtain PPI data. The PPI networks of up- and downregulated DEGs were visualized by Cytoscape (<http://cytoscape.org/>) that is an open source software for visualizing complex networks and integrating these networks with any type of attribute data ([@b23-mmr-17-03-3697]). The Required Confidence score \>0.4 was chosen as the threshold.

Results
=======

### Screening of DEGs

The microarray dataset GSE32078 from GEO database was obtained to identify the DEGs in E13.5 and E15.5 hearts of embryos from diabetic mice compared with their respective controls. Totally, 869 DEGs were obtained in E13.5 group when compared with the control group, including 411 up- and 458 downregulated DEGs. Meanwhile, 802 genes were upregulated and 1,295 genes were downregulated in E15.5 group when compared with the control group. Finally, a total of 182 DEGs were shared between E13.5 and E15.5 groups, including 63 up- and 119 downregulated DEGs.

### GO function enrichment analysis of DEGs

According to the GO enrichment analysis, we found that the upregulated DEGs in E13.5 group were mainly enriched in developmental process (P=2.32E-08) and the downregulated DEGs were mainly enriched in organic substance metabolic process (P=2.93E-06). In the E15.5 group, the upregulated DEGs were mainly enriched in cellular process (P=2.64E-19) and the downregulated DEGs were mainly enriched in cellular process (P=2.01E-19). Besides, we also performed the GO function enrichment analysis for the genes that were shared by E13.5 group and E15.5 group. The results showed that the upregulated DEGs were mainly related to cellular process (P=0.00650) and the downregulated DEGs were mainly related to organic substance metabolic process (P=0.00031) ([Fig. 1](#f1-mmr-17-03-3697){ref-type="fig"}).

### KEGG and Reactome pathway analysis of DEGs

KEGG and Reactome enrichment pathway analysis were performed to explore the enriched pathways of the DEGs. The KEGG enrichment analysis results showed that the upregulated DEGs in E13.5 group were enriched in 64 pathways, such as *Icam1*, *H2-M9*, and *4930468A15Rik* were enriched in cell adhesion molecules (CAMs) (P=1.56E-03). The downregulated DEGs in E13.5 group were enriched in 84 pathways, such as *Bmpr1a*, *Tgfbr1* and *Smurf1* were enriched in TGF-β signaling pathway (P=4.03E-03). The upregulated DEGs in E15.5 group were enriched in 129 pathways, such as *Icam1*, *C1s* and *Fcgr2b* were enriched in *Staphylococcus aureus* infection (P=1.80E-04). Meanwhile, the downregulated DEGs in E15.5 group were enriched in 156 pathways, such as *Ero1lb*, *Dnajc3* and *Dnajb11* were enriched in protein processing in endoplasmic reticulum (P=1.27E-03). Moreover, the shared DEGs that were upregulated such as *Cmah* and *Gmppa* were enriched in nucleotide sugar metabolism (P=2.65E-03). And the shared DEGs that were downregulated such as *Akt3*, *Pak3* and *Hgf* were enriched in renal cell carcinoma (P=5.00E-04); *Akt3*, *Pak3* and *Pak1* were enriched in T cell receptor signaling pathway (P=2.60E-03) ([Table I](#tI-mmr-17-03-3697){ref-type="table"}). Reactome enrichment analysis results showed that the upregulated DEGs in E13.5 group were enriched in 154 pathways and the downregulated DEGs in E13.5 group were enriched in 192 pathways. The upregulated DEGs in E15.5 group were enriched in 27 pathways and the downregulated DEGs in E15.5 group were enriched in 24 pathways. In addition, the shared DEGs that were upregulated such as *Nr6a1* and *Esrrg* were enriched in nuclear receptor transcription pathway (P=5.09E-03) and the shared DEGs that were downregulated such as *Pak3* and *Pak1* were enriched in activation of Rac (P=1.85E-03) ([Table II](#tII-mmr-17-03-3697){ref-type="table"}).

### PPI network construction

STRING was used to construct the PPI networks for DEGs. The PPI networks for up- and downregulated DEGs in E13.5 group contained 114 and 112 nodes, respectively ([Fig. 2](#f2-mmr-17-03-3697){ref-type="fig"}); the PPI networks for up- and downregulated DEGs in E15.5 group contained 345 and 562 nodes, respectively ([Fig. 3](#f3-mmr-17-03-3697){ref-type="fig"}). The proteins such as Icam1, Akp3, Stat1 and Brca1 had high connectivity degrees in the PPI networks of E13.5 ([Table III](#tIII-mmr-17-03-3697){ref-type="table"}) and E15.5 ([Table IV](#tIV-mmr-17-03-3697){ref-type="table"}) groups. Additionally, the PPI network for shared DEGs contained 17 nodes and 12 PPI pairs ([Fig. 4](#f4-mmr-17-03-3697){ref-type="fig"}). The shared DEGs with top three connectivity degrees of the PPI network were *Icam1*, *Ncor1* and *Akt3* ([Table V](#tV-mmr-17-03-3697){ref-type="table"}).

Discussion
==========

Maternal diabetes is a relatively common disease that results in an increased incidence of congenital malformations such as neural tube defects and heart defects ([@b9-mmr-17-03-3697]). CHD are the most common type of birth defects and a main cause of birth defects-related mortality and morbidity ([@b24-mmr-17-03-3697],[@b25-mmr-17-03-3697]). It has been reported that CHD are closely associated with maternal diabetes ([@b26-mmr-17-03-3697]). Previous study had screened and analyzed several DEGs in embryonic heart tissues from diabetic mother ([@b4-mmr-17-03-3697]). However, the molecular mechanism between CHD and diabetes remains largely unknown. In this study, we have screened 869 and 1,295 in E13.5 and E15.5 groups, respectively and 182 DEGs were shared by two groups. Moreover, the DEGs such as *Icam1* and *H2-M9* were significantly enriched in cell adhesion molecules (CAMs); DEGs such as *Bmpr1a*, *Tgfbr1* and *Smurf1* were enriched in TGF-β signaling pathway; DEGs such as *Icam1*, *C1s* and *Fcgr2b* were enriched in *Staphylococcus aureus* infection. Finally, several key shared DEGs that were the genes with the top three node degrees in the network were analyzed, including *Icam1*, *Ncor1* and *Akt3*.

Our results showed that *Icam1* had the highest connectivity degree not only in the PPI network of the upregulated DEGs in E13.5 group but also in the PPI network of the shared DEGs. *ICAM1*, also called CD54, is a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system ([@b27-mmr-17-03-3697]) and the protein is considered to participate in atherogenesis by promoting monocyte accumulation in the arterial intima ([@b28-mmr-17-03-3697]). An earlier study has found that the expression of *ICAM1* on endothelial cells and circulating monocytes may be critical for the adhesion of the cells on the vascular endothelium ([@b29-mmr-17-03-3697]). And the expression of *ICAM1* has been also detected on cardiac myocytes both in adult humans with unexplained cardiac dysfunction ([@b30-mmr-17-03-3697]) and animals with myocarditis ([@b31-mmr-17-03-3697],[@b32-mmr-17-03-3697]). According to the pathway enrichment results in our study, we found that *Icam1* were enriched in *Staphylococcus aureus* infection, CAMs and interferon γ signaling. Inflammation is showed to participate in the pathogenesis of type 2 diabetes ([@b33-mmr-17-03-3697]). Upregulation of adhesion molecules such as *ICAM1* is pivotal in the development of inflammatory responses ([@b34-mmr-17-03-3697]). Besides, autoimmune-associated congenital heart block (CHB) may result from pathogenic cross-talk between inflammatory and profibrosing pathways ([@b35-mmr-17-03-3697]). Therefore, *Icam1* might be involved in the development of heart in mouse embryos.

*Ncor1* also had a high node degree in the PPI network for the shared DEGs. It is well known that *Ncor1* is a transcriptional coregulator that controls the activity of many transcription factors (such as *MEF2*, *ERRs*) and has wide-ranging effects on gene expression patterns ([@b36-mmr-17-03-3697]). MEF2 family has been associated with regulation of myocardially-expressed genes within the heart, such as cardiac α-actin ([@b37-mmr-17-03-3697]). *MEF2* is critical for normal heart development and mitochondrial integrity ([@b38-mmr-17-03-3697]). There is a strict relationship between oxygen consumption and cardiac work ([@b39-mmr-17-03-3697]). Oxidative stress is thought to play a particularly critical role in the development of cardiovascular pathology ([@b40-mmr-17-03-3697]). *SIRT1* that is part of Ncor1/SMRT complex ([@b36-mmr-17-03-3697]) could retard aging and confer oxidative stress resistance to the heart *in vivo* ([@b41-mmr-17-03-3697],[@b42-mmr-17-03-3697]). *SMRT* (*Ncor2*), the homolog of *Ncor1*, is also considered to take part in heart formation ([@b43-mmr-17-03-3697]). Thus, *Ncor1*, as a transcriptional coregulator, might regulate several genes that are related to the heart development through several different signaling pathways.

*Akt3* was interacted with *Ncor1* in the PPI network for the shared DEGs. Study has showed that *Akt3* is a member of the Akt subfamily that comprises three closely related isoforms *Akt1*, *Akt2* and *Akt3*. *Akt* regulates several cellular process including metabolism, cell growth, proliferation, survival and angiogenesis ([@b44-mmr-17-03-3697]). Dysregulation of *Akt* leads to many diseases such as cancer, diabetes, cardiovascular and neurological diseases ([@b44-mmr-17-03-3697]). *Akt* has an important role in the functional behavior in the cardiovasculature such as cardiomyocytes, thrombocytes and endothelial cells ([@b44-mmr-17-03-3697]). *Akt1* is demonstrated to be essential for heart development and function ([@b45-mmr-17-03-3697]). In addition, *Akt3* was found to be enriched in most of the KEGG pathways in shared DEGs, especially renal cell carcinoma. Renal insufficiency in patients with acquired heart failure and ischemic heart disease is related to higher mortality and morbidity ([@b46-mmr-17-03-3697]). Therefore, *Akt3* might to be related to the heart development during embryogenesis.

Additionally, there are some limitations in the present study. For example, much more samples should be used to clarify the finding; the expression level of *Icam1*, *Ncor1*, and *Akt3* should be verified by RT-PCR in the maternal diabetes associated with CHD. However, the present study may provide a scientific guidance for future study to clarify the relationship between CHD and diabetes. It is helpful to explain the molecular mechanism of the CHD development in offspring of diabetic pregnancies. These DEGs may be the therapeutic target in the offspring of diabetic pregnancies with CHD.

In conclusion, we have identified many DEGs in embryonic heart tissue samples at E13.5 and E15.5 from diabetic mice using bioinformatics analysis. And we found that the shared DEGs such as *Icam1, Ncor1*, and *Akt3* had high connectivity degrees in the network. Our study implied that maternal diabetes could affect *Icam1, Ncor1*, and *Akt3* which are critical in the heart development during embryogenesis and might result in CHD. However, more research is needed to confirm these results and further explore the complex molecular mechanism.
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###### 

Enrichment analysis of top five KEGG pathways for DEGs.

  DEGs                               Term       Description                                    P-value        Gene ID                                                                          Count
  ---------------------------------- ---------- ---------------------------------------------- -------------- -------------------------------------------------------------------------------- -------
  Upregulated DEGs in E13.5          mmu04514   Cell adhesion molecules (CAMs)                 1.56×10^−03^   *Icam1*, *H2-M9*, *4930468A15Rik*, *H2-D1*, *Itga4*, *H2-Ob*, *Cntnap2, Nrxn2*     8
                                     mmu04672   Intestinal immune network for IgA production   3.77×10^−03^   *Gm13306*, *Itga4*, *Il15*, *H2-Ob*                                                4
                                     mmu05330   Allograft rejection                            8.24×10^−03^   *H2-M9*, *H2-D1*, *H2-Ob*, *Il12b*                                                 4
                                     mmu04940   Type I diabetes mellitus                       1.24×10^−02^   *H2-M9*, *H2-D1*, *H2-Ob*, *Il12b*                                                 4
                                     mmu04146   Peroxisome                                     2.74×10^−02^   *Agps*, *Nudt19*, *Slc25a17*, *Acsbg2*                                             4
  Downregulated DEGs in E13.5        mmu04350   TGF-β signaling pathway                        4.03×10^−03^   *Bmpr1a*, *Tgfbr1*, *Smurf1*, *Ltbp1 Lefty2, Thbs2,*                               6
                                     mmu05211   Renal cell carcinoma                           9.14×10^−03^   *Akt3*, *Pak3*, *Hgf*, *Pak1*, *Pik3ca*                                            5
                                     mmu04080   Neuroactive ligand-receptor interaction        1.05×10^−02^   *Prlr*, *Gabra1*, *Tshr*, *Gabra2*, *Gabrb2*, *Crhr2*...                         11
                                     mmu05223   Non-small cell lung cancer                     1.66×10^−02^   *Akt3*, *Pik3ca*, *Stk4*, *Rarb*                                                   4
                                     mmu04210   Apoptosis                                      1.87×10^−02^   *Irak3*, *Il3*, *Akt3*, *Endod1*, *Pik3ca*                                         5
  Upregulated DEGs in E15.5          mmu05150   *Staphylococcus aureus* infection              1.80×10^−04^   *Icam1*, *C1s*, *Fcgr2b*, *H2-Ab1*, *C2*, *Fpr2*, *Cfh*, *H2-Aa*                   8
                                     mmu04514   Cell adhesion molecules (CAMs)                 1.18×10^−03^   *Icam1*, *Vcan*, *H2-K1*, *Cd80*, *Ncam1*...                                     13
                                     mmu04145   Phagosome                                      1.61×10^−03^   *Lamp2*, *H2-K1*, *Tap2*, *Tuba4a*, *Thbs2*, *Fcgr2b*...                         14
                                     mmu05219   Bladder cancer                                 2.20×10^−03^   *Rb1*, *Mmp9*, *Myc*, *E2f3*, *Egfr*, *E2f2*                                       6
                                     mmu05220   Chronic myeloid leukemia                       2.27×10^−03^   *Bcl2l1*, *Rb1*, *Myc*, *Cblb*, *E2f3*, *Sos2*, *E2f2*, *Abl1*                     8
  Downregulated DEGs in E15.5        mmu04141   Protein processing in endoplasmic reticulum    1.27×10^−03^   *Ero1lb*, *Dnajc3*, *Dnajb11*, *Sec62*, *Derl1*, *Mapk8*...                      18
                                     mmu01100   Metabolic pathways                             2.25×10^−03^   *Phgdh*, *B3gnt5*, *Sucla2*, *Alad*, *B4galt6*, *Mmab*...                        77
                                     mmu04977   Vitamin digestion and absorption               4.84×10^−03^   *Tcn2*, *Rbp2*, *Plb1*, *Lrat*, *Slc5a6*                                           5
                                     mmu04010   MAPK signaling pathway                         9.22×10^−03^   *Cacna1a*, *Ptpn5*, *Mapk8*, *Cacna2d1*, *Akt3*, *Gna12*...                      22
                                     mmu00512   Mucin type O-Glycan biosynthesis               9.57×10^−03^   *Gcnt3*, *C1galt1*, *Galnt2*, *Galnt7*, *Galnt15*                                  5
  Upregulated genes in shared DEGs   mmu00520   Amino sugar and nucleotide sugar metabolism    2.65×10^−03^   *Cmah*, *Gmppa*                                                                    2
                                     mmu01100   Metabolic pathways                             6.08×10^−01^   *Lias*, *Gmppa*                                                                    2
  Downregulated                      mmu05211   Renal cell carcinoma                           5.00×10^−04^   *Akt3*, *Pak3*, *Hgf*, *Pak1*,                                                     4
  genes in shared DEGs               mmu04660   T cell receptor signaling pathway              2.60×10^−03^   *Akt3*, *Pak3*, *Pak1*, *Grap2*                                                    4
                                     mmu04730   Long-term depression                           6.09×10^−03^   *Cacna1a*, *Gna12*, *Ppp1r17*                                                      3
                                     mmu04210   Apoptosis                                      9.95×10^−03^   *Akt3*, *Il3*, *Endod1*                                                            3
                                     mmu04012   ErbB signaling pathway                         1.03×10^−02^   *Akt3*, *Pak3*, *Pak1*                                                             3
                                     mmu04510   Focal adhesion                                 1.96×10^−02^   *Akt3*, *Pak3*, *Hgf*, *Pak1*,                                                     4
                                     mmu04010   MAPK signaling pathway                         5.02×10^−02^   *Akt3*, *Cacna1a*, *Gna12*, *Pak1*                                                 4
                                     mmu04080   Neuroactive ligand-receptor interaction        5.48×10^−02^   *Prlr*, *Tshr*, *Gabrb2*, *Crhr2*                                                  4
                                     mmu04630   Jak-STAT signaling pathway                     4.49×10^−02^   *Akt3*, *Prlr*, *Il3*                                                              3
                                     mmu00140   Steroid hormone biosynthesis                   3.31×10^−02^   *Hsd17b7*, *Hsd11b2*                                                               2

E13.5, embryonic day 13.5; E15.5, embryonic day 15.5; DEGs, differentially expressed genes; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes.

###### 

Enrichment analysis of top five Reactome pathways for DEGs.

  DEGs                          Term      Description                                                                               P-value        Gene ID                                                             Count
  ----------------------------- --------- ----------------------------------------------------------------------------------------- -------------- ------------------------------------------------------------------- -------
  Upregulated DEGs in E13.5     4809882   Neuronal system                                                                           2.10×10^−03^   *Gjd2*, *Braf*, *Kcnb1*, *Chrna3*, *Gabrg2*, *Gls*...               10
                                4810204   Neurotransmitter receptor binding and downstream transmission in the post-synaptic cell   2.14×10^−03^   *Braf, Chrna3, Gabrg2, Arhgef9, Ap2a2, Epb4.1l1, Rps6ka2*             7
                                4810917   Interferon γ signaling                                                                    2.64×10^−03^   *Icam1, Oas1h, Irf7, Sp100, H2-D1*                                    5
                                4809881   Transmission across chemical synapses                                                     3.10×10^−03^   *Braf, Chrna3, Gabrg2, Gls, Arhgef9, Ap2a2, Epb4.1l1, Rps6ka2*        8
                                4810848   Regulation of cytoskeletal remodeling and cell spreading by IPP complex components        5.26×10^−03^   *Parvb, Pxn*                                                          2
  Downregulated DEGs in E13.5   4810408   GABA receptor activation                                                                  3.56×10^−04^   *Gabra1, Gabra2, Gabrb2, Gngt2, Kcnj3, Kcnj9*                         6
                                4809881   Transmission across chemical synapses                                                     8.56×10^−04^   *Cacna1a, Gabra1, Gabra2, Gabrb2, Camk2b, Gngt2*...                 10
                                4809882   Neuronal system                                                                           9.71×10^−04^   *Cacna1a, Gabra1, Gabra2, Gabrb2, Camk2b, Kcnq5*...                 12
                                4810957   GABA A receptor activation                                                                1.01×10^−03^   *Gabra1, Gabra2, Gabrb2*                                              3
                                4810204   Neurotransmitter receptor binding and downstream transmission in the post-synaptic cell   1.68×10^−03^   *Gabra1, Gabra2, Gabrb2, Camk2b, Gngt2, Kcnj3, Kcnj9, Chrnb3*         8
  Upregulated DEGs in E15.5     4810016   Immune system                                                                             1.13×10^−07^   *Ifitm3, Ifitm6, Lgals3, H2-K1, Tap2, Bcl2l1*...                    64
                                4810918   Interferon signaling                                                                      5.69×10^−05^   *Icam1, Stat1, Irf1, Oas1h, Ncam1, Ifnar2*...                       13
                                4810008   EGFR interacts with phospholipase C-γ                                                     5.88×10^−05^   *Adcy7, Plcg1, Adrbk1, Egfr, Creb1, Camk4, Adcy9*                     7
                                4810917   Interferon γ signaling                                                                    6.00×10^−05^   *Icam1, Stat1, H2-K1, Irf1, Oas1h, Ncam1, Socs3*...                 10
                                4810011   PLCG1 events in ERBB2 signaling                                                           7.26×10^−05^   *Adcy7, Plcg1, Adrbk1, Egfr, Creb1, Camk4, Adcy9*                     7
  Downregulated DEGs in E15.5   4809896   Metabolism of water-soluble vitamins and cofactors                                        2.69×10^−03^   *Amn, Mmaa, Mmab, Tcn2, Slc23a2, Mthfr, Rfk, Slc5a6, Mocs1, Ppcs*   10
                                4809897   Metabolism of vitamins and cofactors                                                      2.69×10^−03^   *Amn, Mmaa, Mmab, Tcn2, Slc23a2, Mthfr, Rfk, Slc5a6, Mocs1, Ppcs*   10
                                4809898   Defective TCN2 causes hereditary megaloblastic anemia                                     2.69×10^−03^   *Amn, Mmaa, Mmab, Tcn2, Slc23a2, Mthfr, Rfk, Slc5a6, Mocs1, Ppcs*   10
                                4809899   Defects in cobalamin (B12) metabolism                                                     2.69×10^−03^   *Amn, Mmaa, Mmab, Tcn2, Slc23a2, Mthfr, Rfk, Slc5a6, Mocs1, Ppcs*   10
                                4809900   Defects in vitamin and cofactor metabolism                                                2.69×10^−03^   *Amn, Mmaa, Mmab, Tcn2, Slc23a2, Mthfr, Rfk, Slc5a6, Mocs1, Ppcs*   10
  Upregulated                   4810720   Nuclear receptor genes in shared                                                          5.09×10^−03^   *Nr6a1, Esrrg* transcription pathway\'                                2
  DEGs                          4810917   Interferon γ signaling                                                                    9.26×10^−03^   *Icam1, Oas1h*                                                        2
                                4810918   Interferon signaling                                                                      2.35×10^−02^   *Icam1, Oas1h*                                                        2
                                4810429   Generic transcription pathway                                                             3.07×10^−02^   *Nr6a1, Esrrg*                                                        2
                                4810016   Immune system                                                                             6.30×10^−02^   *Icam1, Oas1h, C6, Fbxw11, Kif2a*                                     5
  Downregulated                 4810839   Activation of Rac                                                                         1.85×10^−03^   *Pak3, Pak1*                                                          2
  genes in shared               4810573   CD28 co-stimulation                                                                       5.02×10^−03^   *Pak1, Grap2*                                                         2
  DEGs                          4810613   Generation of second messenger molecules                                                  5.02×10^−03^   *Pak1, Grap2*                                                         2
                                4810625   Signaling by Robo receptor                                                                9.02×10^−03^   *Pak3, Pak1*                                                          2
                                4810145   FCERI mediated MAPK activation                                                            1.55×10^−02^   *Pak1*, *Grap2*                                                       2

E13.5, embryonic day 13.5; E15.5, embryonic day 15.5; DEGs, differentially expressed genes.

###### 

DEGs with the top 10% connectivity degree in the PPI network in E13.5 group.

  DEGs                 ID      Degree   ID       Degree   ID       Degree   ID      Degree
  -------------------- ------- -------- -------- -------- -------- -------- ------- --------
  Upregulated DEGs     Icam1     9      H2-M9    5        Ube2t    4        Calb1   3
                       H2-L      8      Gabrg2   5        Sgip1    4        Itga4   3
                       Irf7      7      Pxn      5        Ap2a2    3                
                       Oas1h     5      Il12b    4        Rnf2     3                
  Downregulated DEGs   Akp3    13       Ncor1    7        Pik3ca   6        Akt3    5
                       Nr3c1   10       Stat2    6        Bmpr1a   6        Gna15   5
                       Ar        9      Il3      6        Gngt2    5        Mut     4

DEGs, differentially expressed genes; PPI, protein-protein interaction; E13.5, embryonic day 13.5.

###### 

DEGs with the top 10% connectivity degree in the PPI network in E15.5 group.

  DEGs                 ID      Degree   ID       Degree   ID        Degree   ID        Degree   ID         Degree
  -------------------- ------- -------- -------- -------- --------- -------- --------- -------- ---------- --------
  Upregulated DEGs     Stat1   38       Mmp9     19       Ifih1     16       Ezr       13       Lgals3bp   12
                       Egfr    37       Irf1     18       Cxcl1     15       Mbp       13       Oasl2      12
                       Icam1   27       Ccr2     18       Ifi35     14       Hnrnpa1   13       Rbm25      12
                       Myc     27       Fpr2     18       Actb      14       Rmcs2     13       Ccr9       12
                       Pten    25       Ncam1    17       Ccl6      14       Cpsf6     13       H2-Aa      12
                       Stat2   21       Plcg1    17       Cblb      14       Adrbk1    12       Abl1       12
                       Yes1    20       Creb1    16       H2-K1     14       Rsad2     12                  
  Downregulated DEGs   Brca1   33       Dlgap5   20       Tmem48    17       Rpn1      12       Hao1       10
                       Chek1   30       Creb1    20       Hspa5     16       Kcnj11    12       Ugt2b5     10
                       Bub1    29       Aspm     20       Lsm4      14       Med1      11       Abcb11     10
                       Rrm2    26       Zwint    20       Akt3      14       Calr      11       Gnao1      10
                       Sgol2   25       Cenpm    19       Sec61a1   13       Kalrn     11       Gabrg2     10
                       Cep55   25       Spc24    19       Lpar3     13       Slc10a1   11       Cd40       10
                       Plk4    24       Eme1     19       Hjurp     13       Rgn       10       Chrm4      10
                       Tpx2    24       Foxm1    19       Nasp      13       Cfi       10       Ppp2r1a      9
                       Kif23   23       Xpo1     18       Igf1r     13       Ddost     10       Nfatc2       9
                       Ska1    23       Troap    18       Gucy1b3   13       Prkx      10       Hpd          9
                       Prc1    23       Oip5     17       Ncor1     12       Rae1      10       Fanci        9

DEGs, differentially expressed genes; PPI, protein-protein interaction; E15.5, embryonic day 15.5.

###### 

Connectivity degrees in the PPI network for shared DEGs in E13.5 and E15.5 groups.

  ID      Degree   ID        Degree   ID      Degree   ID     Degree
  ------- -------- --------- -------- ------- -------- ------ --------
  Icam1   3        Oca2      1        Hgf     1        Tpx2   1
  Ncor1   3        Slc45a2   1        Esrrg   1        Il3    1
  Akt3    2        Appl1     1        Pak3    1               
  Oas1h   2        Sgip1     1        Pak1    1               
  Nr6a1   2        Calb1     1        Iqcd    1               

DEGs, differentially expressed genes; PPI, protein-protein interaction; E13.5, embryonic day 13.5; E15.5, embryonic day 15.5.

[^1]: Contributed equally
